The Stem Cell Solutions for Intractable Diseases
Home > R&D > Recent Publications (since 2020)
Recent Publications (since 2020)
- 16. ISSCR standards for the use of human stem cells in basic research. Stem Cell Reports (2023)
- 15. A novel HDAC6 inhibitor, CKD-504, is effective in treating preclinical models of Huntington's disease. BMB Reports (2023)
- 14. Lessons learnt, and still to learn, in first in human stem cell trials. Stem Cell Reports (2023)
- 13. Mitochondrial genome mutations and neuronal dysfunction of induced pluripotent stem cells derived from patients with Alzheimer's disease. Cell Proliferation (2022)
- 12. SUPT4H1-edited stem cell therapy rescues neuronal dysfunction in a mouse model for Huntington's disease. NPJ Regenerative Medicine (2022)
- 11. Therapeutic effect of BDNF-overexpressing human neural stem cells (F3.BDNF) in a contusion model of spinal cord injury in rats. International Journal of Molecular Medicine (2021)
- 10. Human iPSC-derived neural precursor cells differentiate into multiple cell types to delay disease progression following transplantation into YAC128 Huntingtos's disease mouse model. Cell Proliferation (2021)
- 09. Intracerebral transplantation of GMP-grade human umbilical cord-derived mesenchymal stromal cells in effective in treating the rodent model of subacute-stage ischemic stroke. Frontiers in Cellular Nuroscience (2020)
- 08. Neural transplants from human induced pluripotent stem cells rescue the pathology and behavioral defects in a rodent model of Huntington's Disease. Frontiers in Neuroscience (2020)
- 07. Neural stem cells derived from the developing forebrain of YAC128 mice exhibit pathological features of Huntington's disease. Cell Proliferation (2020)
- 06. Modeling of frontotemporal dementia using iPSC technology. International Journal of Molecular Sciences (2020)
- 05. Intracerebral transplantation of HLA-homozygous human iPSC-derive neural precursor ameliorates the behavioral and pathological deficits in a rodent model of ischemic stroke. Cell Proliferation (2020)
- 04. Intracerebral transplantation of BDNF-overexpressing human neural stem cells (HB1.F3.BDNF) promotes migration, differentiation, and functional recovery in a rodent model of Huntington's disease. Experimental Neurobiology (2020)
- 03. Implatation of the clinical-grade human neural stem cell line, CTXoEo3, rescues the behavioral and pathological deficits in the quinolinic acid-lesioned rodent model of Huntington's disease. Stem Cells (2020)
- 02. Multimodal therapeutic effects of neural precursor cells derived from human induced pluripotent stem cells through episomal plasmid-based reprogramming in a rodent model of ischemic stroke. Stem Cells International (2020)
- 01. Pathological manifestation of the induced pluripotent stem cell-derived contical neurons from an early-onset Alzheimer's disease patient carrying a presenilin-1 mutation(S170F). Cell Proliferation (2020)
- 16. ISSCR standards for the use of human stem cells in basic research. Stem Cell Reports (2023)
- 15. A novel HDAC6 inhibitor, CKD-504, is effective in treating preclinical models of Huntington's disease. BMB Reports (2023)
- 14. Lessons learnt, and still to learn, in first in human stem cell trials. Stem Cell Reports (2023)
- 13. Mitochondrial genome mutations and neuronal dysfunction of induced pluripotent stem cells derived from patients with Alzheimer's disease. Cell Proliferation (2022)
- 12. SUPT4H1-edited stem cell therapy rescues neuronal dysfunction in a mouse model for Huntington's disease. NPJ Regenerative Medicine (2022)
- 11. Therapeutic effect of BDNF-overexpressing human neural stem cells (F3.BDNF) in a contusion model of spinal cord injury in rats. International Journal of Molecular Medicine (2021)
- 10. Human iPSC-derived neural precursor cells differentiate into multiple cell types to delay disease progression following transplantation into YAC128 Huntingtos's disease mouse model. Cell Proliferation (2021)
- 09. Intracerebral transplantation of GMP-grade human umbilical cord-derived mesenchymal stromal cells in effective in treating the rodent model of subacute-stage ischemic stroke. Frontiers in Cellular Nuroscience (2020)
- 08. Neural transplants from human induced pluripotent stem cells rescue the pathology and behavioral defects in a rodent model of Huntington's Disease. Frontiers in Neuroscience (2020)
- 07. Neural stem cells derived from the developing forebrain of YAC128 mice exhibit pathological features of Huntington's disease. Cell Proliferation (2020)
- 06. Modeling of frontotemporal dementia using iPSC technology. International Journal of Molecular Sciences (2020)
- 05. Intracerebral transplantation of HLA-homozygous human iPSC-derive neural precursor ameliorates the behavioral and pathological deficits in a rodent model of ischemic stroke. Cell Proliferation (2020)
- 04. Intracerebral transplantation of BDNF-overexpressing human neural stem cells (HB1.F3.BDNF) promotes migration, differentiation, and functional recovery in a rodent model of Huntington's disease. Experimental Neurobiology (2020)
- 03. Implatation of the clinical-grade human neural stem cell line, CTXoEo3, rescues the behavioral and pathological deficits in the quinolinic acid-lesioned rodent model of Huntington's disease. Stem Cells (2020)
- 02. Multimodal therapeutic effects of neural precursor cells derived from human induced pluripotent stem cells through episomal plasmid-based reprogramming in a rodent model of ischemic stroke. Stem Cells International (2020)
- 01. Pathological manifestation of the induced pluripotent stem cell-derived contical neurons from an early-onset Alzheimer's disease patient carrying a presenilin-1 mutation(S170F). Cell Proliferation (2020)